About MedTrust Online LLC
MedTrust Online LLC, www.medtrust-online.com, headquartered in Scottsdale, Arizona, provides oncologists with clinically useful technology applications and solutions. MedTrust Online brings together experts in Oncology, information technology, computational biology, pharmaceutical drug development, and personalized medicine to capture, organize, analyze, integrate and present the most up-to-date medical facts from a vast array of sources. This data is provided to doctors in a comprehensive yet concise way unavailable anywhere else.
About Exiqon Diagnostics
Exiqon Diagnostics (the tradename for Oncotech, Inc, a wholly owned subsidiary of Exiqon A/S), is a leader in personalizing medicine for cancer patients. As a CLIA and CAP-certified laboratory, Exiqon Diagnostics develops and performs novel molecular and cell-based oncology assays to help physicians individualize and optimize treatment selection for their patients. In addition to the Extreme Drug Resistance (EDR(R)) Assay, Exiqon Diagnostics offers an extensive test menu of prognostic and predictive molecular oncology biomarkers using fluorescence in situ hybridization (FISH), flow cytometry, polymerase chain reaction (PCR) and other cutting-edge technologies.
For further information please visit www.exiqondiagnostics.com.
Exiqon is a biotech company with activities in three business areas where the company's technologies provide a competitive advantage: Sale of diagnostic tests (Exiqon Diagnostics), sale of innovative research products for miRNA research (Exiqon Life Sciences), and in contract research together with pharmaceutical companies (Exiqon Pharma Services).
Exiqon is dedicated to personalizing the treatment selection
|SOURCE MedTrust Online|
Copyright©2009 PR Newswire.
All rights reserved